{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:01:58Z","timestamp":1790146918199,"version":"4.0.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bronchoalveolar lavage (BAL) is an important adjunctive tool in the multidisciplinary evaluation of interstitial lung diseases (ILDs), particularly hypersensitivity pneumonitis (HP) and nonspecific interstitial pneumonia (NSIP). However, considerable overlap in BAL cellular profiles and inconsistent lymphocyte thresholds limit its independent diagnostic value. This systematic review summarizes current evidence regarding the diagnostic and prognostic utility of BAL cellular analysis in differentiating HP from NSIP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search of PubMed\/MEDLINE, Embase, CENTRAL identified studies evaluating BAL cellular, immunophenotypic, and biomarker findings in HP and NSIP. Study selection followed PRISMA recommendations. Owing to methodological heterogeneity, the evidence was synthesized narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-one studies met the inclusion criteria. BAL lymphocytosis consistently supported the diagnosis of HP, particularly at thresholds above 30%, although higher cut-offs improved specificity at the expense of sensitivity. Considerable overlap between HP and NSIP was observed, especially in fibrotic disease, limiting the diagnostic performance of isolated lymphocyte percentages. Emerging BAL biomarkers, including CD4\/CD8 ratio, NK\/NKT-cell subsets, IL-9 signaling, KL-6, and flow cytometric immunophenotyping, showed potential to improve differential diagnosis. In addition, higher BAL lymphocyte counts were associated with favorable treatment response and improved prognosis in selected HP and NSIP populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>BAL cellular analysis remains a valuable complementary diagnostic tool rather than a standalone test for distinguishing HP from NSIP. Accurate interpretation requires integration with exposure history, high-resolution computed tomography, histopathology when available, and multidisciplinary discussion. Standardized BAL protocols and prospective validation of advanced immunophenotypic biomarkers are needed to improve diagnostic precision and clinical decision-making in fibrotic ILDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261397405<\/jats:ext-link>\n                      , identifier PROSPERO (CRD420261397405).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1920436","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:20:44Z","timestamp":1790144444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bronchoalveolar lavage lymphocyte patterns in hypersensitivity pneumonitis and nonspecific interstitial pneumonia: a systematic review"],"prefix":"10.3389","volume":"13","author":[{"given":"Hatice","family":"Elmas","sequence":"first","affiliation":[{"name":"Section Cytopathology, Institute of Pathology, University Medical Center Hamburg-Eppendorf UKE","place":["Hamburg, Germany"]},{"name":"Airway Research Center North (ARCN), German Center for Lung Research (DZL)","place":["Giessen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Welker","sequence":"additional","affiliation":[{"name":"Section Cytopathology, Institute of Pathology, University Medical Center Hamburg-Eppendorf UKE","place":["Hamburg, Germany"]},{"name":"Airway Research Center North (ARCN), German Center for Lung Research (DZL)","place":["Giessen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00063198-200109000-00002","article-title":"Bronchoalveolar lavage in interstitial lung disease","volume":"7","author":"Costabel","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.21037\/jtd-20-651","article-title":"Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases","volume":"12","author":"Davidson","year":"2020","journal-title":"J Thorac Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults: an official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.chest.2021.03.066","article-title":"Diagnosis and evaluation of hypersensitivity pneumonitis","volume":"160","author":"Fern\u00e1ndez P\u00e9rez","year":"2021","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2000206","DOI":"10.1183\/13993003.00206-2020","article-title":"Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis","volume":"56","author":"Adderley","year":"2020","journal-title":"Eur Respir J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1513\/AnnalsATS.202005-420OC","article-title":"Bronchoalveolar lavage lymphocytes in the diagnosis of hypersensitivity pneumonitis among patients with interstitial lung disease","volume":"17","author":"Patolia","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1183\/09031936.04.00101303","article-title":"Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases","volume":"24","author":"Welker","year":"2004","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/diagnostics13050935","article-title":"Bronchoalveolar lavage cell count and lymphocytosis are the important discriminators between fibrotic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis","volume":"13","author":"Sobiecka","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.chest.2024.07.166","article-title":"BAL fluid cellular analysis and radiologic patterns in patients with fibrotic interstitial lung disease","volume":"167","author":"Grant-Orser","year":"2025","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"108827","DOI":"10.1016\/j.clim.2021.108827","article-title":"Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases","volume":"230","author":"Bergantini","year":"2021","journal-title":"Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/biom15010122","article-title":"Evaluating the diagnostic value of lymphocyte subsets in bronchoalveolar lavage fluid and peripheral blood across various diffuse interstitial lung disease subtypes","volume":"15","author":"Harada","year":"2025","journal-title":"Biomolecules (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00408-020-00389-4","article-title":"Utility of bronchoalveolar lavage and transbronchial biopsy in patients with interstitial lung disease","volume":"198","author":"Adams","year":"2020","journal-title":"Lung"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.20452\/pamw.2784","article-title":"Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases","volume":"125","author":"Przybylski","year":"2015","journal-title":"Pol Arch Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"17534666221089468","DOI":"10.1177\/17534666221089468","article-title":"Clinical characteristics and prognostic factors of fibrotic nonspecific interstitial pneumonia","volume":"16","author":"Cho","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12931-021-01726-8","article-title":"Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia","volume":"22","author":"Yamagata","year":"2021","journal-title":"Respir Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10238-020-00608-5","article-title":"BAL biomarkers\u2019 panel for differential diagnosis of interstitial lung diseases","volume":"20","author":"d\u2019 Alessandro","year":"2020","journal-title":"Clin Exp Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"152258","DOI":"10.1016\/j.imbio.2022.152258","article-title":"IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease","volume":"227","author":"Jehn","year":"2022","journal-title":"Immunobiology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1183\/09031936.00069509","article-title":"Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?","volume":"38","author":"Meyer","year":"2011","journal-title":"Eur Respir J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"26295","DOI":"10.1038\/s41598-025-12180-7","article-title":"Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia","volume":"15","author":"Enomoto","year":"2025","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s00432-021-03750-z","article-title":"Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case\u2013control study","volume":"148","author":"Kowalski","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/j.semdp.2018.08.003","article-title":"The utility of bronchoalveolar lavage in the evaluation of interstitial lung diseases: a clinicopathological perspective","volume":"35","author":"Gharsalli","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.4081\/monaldi.2020.1307","article-title":"Hypersensitivity pneumonitis: clinical, radiological and pathological profile of 103 patients from North India","volume":"90","author":"Kumar","year":"2020","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/biom15040597","article-title":"Diagnostic utility of bronchoalveolar lavage flow cytometric leukocyte profiling in interstitial lung disease and infection","volume":"15","author":"Novoa-Bolivar","year":"2025","journal-title":"Biomolecules"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1582714","DOI":"10.3389\/fmed.2025.1582714","article-title":"Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis","volume":"12","author":"Mir","year":"2025","journal-title":"Front Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"119274","DOI":"10.1016\/j.lfs.2021.119274","article-title":"Insights on chronic hypersensitivity pneumonitis\\u0027 treatment: Factors associated with a favourable response to azathioprine","volume":"272","author":"Raimundo","year":"2021","journal-title":"Life Sci."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13598","article-title":"Evaluation of cases with hypersensitivity pneumonia: 10 year analysis","author":"Koyuncu","year":"2023","journal-title":"Clin Respir J."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13075-024-03371-0","article-title":"Correlation of high-resolution computed tomography and immunological bronchoalveolar lavage in interstitial lung disease at the onset of inflammatory rheumatic diseases: implications for diagnosis and therapeutic strategies","volume":"26","author":"Hoffmann","year":"2024","journal-title":"Arthritis Res Ther."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1164\/rccm.201710-1986OC","article-title":"HP Delphi Collaborators. Identification of diagnostic criteria for chronic hypersensitivity pneumonitis: an international modified Delphi survey","volume":"197","author":"Morisset","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.2169\/internalmedicine.0841-18","article-title":"Elevated Levels of Intelectin-1, a Pathogen-binding Lectin, in the BAL Fluid of Patients with Chronic Eosinophilic Pneumonia and Hypersensitivity Pneumonitis","volume":"57","author":"Shinohara","year":"2018","journal-title":"Intern Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1920436\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:20:44Z","timestamp":1790144444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1920436\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":29,"alternative-id":["10.3389\/fmed.2026.1920436"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1920436","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1920436"}}